Compare studies and check their requirements with the research team.
This summary needs review. Please check the official study record and contact the research team for details.
In TallahasseeThis study is directly about Depression.
This summary needs review. Please check the official study record and contact the research team for details.
In ToulouseThis study is directly about Depression.
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listedThis study is directly about Depression.
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including La JollaThis study is directly about Depression.
This summary needs review. Please check the official study record and contact the research team for details.
In Saint-Sébastien-de-MorsentThis study is directly about Depression.
This summary needs review. Please check the official study record and contact the research team for details.
In LondonThis study is directly about Depression.
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listedThis study is directly about Depression.
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including BirminghamThis study is directly about Depression.
This study was withdrawn. It is testing Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant for treatment-resistant depression.
Location not clearly listedThis study is directly about Depression.
This study is completed in the United States. It is testing esketamine Nasal Spray, Administered for treatment-resistant depression.
Multiple locations, including BirminghamThis study is directly about Depression.
This study is completed in the United States, in France, in Canada, .... It is testing intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.
Multiple locations, including BirminghamThis study is directly about Depression.
This study is completed in the United States. It is testing ketamine for treatment-resistant depression.
Multiple locations, including BirminghamThis study is directly about Depression.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.